CYRUS BIOTECHNOLOGY
Cyrus Biotechnology builds software tools to accelerate basic research in biotech, pharma, and industrial biotechnology. Cyrus Bench delivers an enterprise version of the Rosetta molecular modeling and design toolkit, with the associated array of bio-molecular computation tools. It was founded in 2014 and headquartered in Seattle, Washington.
CYRUS BIOTECHNOLOGY
Industry:
Biotechnology Nutrition Software
Founded:
2014-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.cyrusbio.com
Total Employee:
11+
Status:
Active
Contact:
(206)258-6561
Email Addresses:
[email protected]
Total Funding:
46.84 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Domain Not Resolving
Similar Organizations
1200 Pharma
1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.
Genospace
Genospace is a medicine software platform that genomics is driving the development of precision medicine.
Proscia
Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-06 | Orthogonal Biologics | Orthogonal Biologics acquired by Cyrus Biotechnology | N/A |
Investors List
Selecta Biosciences
Selecta Biosciences investment in Series B - Cyrus Biotechnology
Washington Research Foundation
Washington Research Foundation investment in Series B - Cyrus Biotechnology
OrbiMed
OrbiMed investment in Series B - Cyrus Biotechnology
iSELECT FUND
iSELECT FUND investment in Series B - Cyrus Biotechnology
The Yard Ventures
The Yard Ventures investment in Series B - Cyrus Biotechnology
Agent Capital
Agent Capital investment in Series B - Cyrus Biotechnology
Trinity Ventures
Trinity Ventures investment in Series B - Cyrus Biotechnology
W Fund
W Fund investment in Series B - Cyrus Biotechnology
Alumni Ventures
Alumni Ventures investment in Series A - Cyrus Biotechnology
Trinity Ventures
Trinity Ventures investment in Series A - Cyrus Biotechnology
Official Site Inspections
http://www.cyrusbio.com Semrush global rank: 9.73 M Semrush visits lastest month: 114
- Host name: 233.254.208.35.bc.googleusercontent.com
- IP address: 35.208.254.233
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Cyrus Biotechnology"
Cyrus Biotechnology - Crunchbase Company Profile
Organization. Cyrus Biotechnology . Connect to CRM . Save . Summary. …See details»
Cyrus Biotechnology - LinkedIn
Cyrus Biotechnology is a pre-clinical-stage biotech company combining protein design and screening to create novel biologics for serious unmet medical needs. Using this approach, we …See details»
Cyrus Biotechnology Overview | SignalHire Company Profile
Organization Website. cyrusbio.com . Social Links. Phone Number. 206-258-6561. Cyrus Biotechnology industries. Biotech, Biotechnology Headquarters Location. 3005 1st Ave, …See details»
Cyrus Biotechnology: Revenue, Worth, Valuation & Competitors …
About Cyrus Biotechnology. Cyrus Biotechnology is a Biotech related company founded in 2014 and based in Seattle with 35 employees an estimated revenue of $5.4M, and. It has 10 …See details»
Cyrus Biotech spins out company to expand reach of versatile drug ...
Jun 11, 2024 Levitate Bio's CEO Sam DeLuca, left, and Karen Khar, executive vice president of sales and business development. (LinkedIn Photos) Seattle startup CyrusSee details»
Cyrus Biotechnology Spins out Levitate Bio, a Protein AI ... - BioSpace
Jun 11, 2024 “We are excited to build a for-profit organization to bridge the gap between academic and tech industry innovation and applied drug discovery that can make a difference …See details»
Cyrus Biotechnology - Craft
Cyrus Biotechnology has 5 employees across 2 locations and $8.85 m in total funding,. See insights on Cyrus Biotechnology including office locations, competitors, revenue, financials, …See details»
Cyrus Biotechnology Company Overview, Contact Details
University of Illinois invested into Cyrusbio $18M on Dec 6th '21. Cyrus Biotechnology, Inc., a Seattle-based biotechnology firm with a proprietary software platform for biologics discovery, …See details»
Portfolio - Sahsen
Cyrus Biotechnology, Inc. Rosetta software as a cloud computing service for the biopharmaceutical industry. Cyrus, founded in 2015 by Lucas Nivon, delivers the most …See details»
Cyrus Biotechnology - BIO International Convention | BIO
Jun 8, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. Cyrus …See details»
Cyrus Biotechnology - Overview, News & Similar companies
Dec 5, 2021 Who is Cyrus Biotechnology. Cyrus Biotechnology, Inc. is a privately-held Seattle-based biotechnology software company offering software and partnerships for protein …See details»
Cyrus Biotechnology | Startup Profile and Investments
Cyrusbio.com. Cyrus Biotechnology - Company Details Cyrus Biotechnology, founded in 2014, is a pre-clinical-stage biotech company based in Seattle, WA. With a focus on discovering novel …See details»
Cyrus Biotechnology - workinbiotech.com
Cyrusbio.com. linkedin.com . job board . Business: Biological computation tools. Drug notes: ACE2v2 Clin0 Covid; 4 add'l products RD. About: Cyrus Bio is an AI-driven discovery …See details»
Cyrus Biotechnology Spins out Levitate Bio, a Protein AI ...
Jun 11, 2024 Learn more at cyrusbio.com NOTICE: The information contained in this document is dated as of June 11, 2024. Cyrus Biotechnology, Inc. (the Company) disclaims any …See details»
Cyrus Biotechnology Inc. - CMOCRO - Domain Name
Cyrus Biotechnology, Inc. is a a pre-clinical-stage biotech company combining protein design and screening to create novel biologics for serious unmet medical needs. Using this approach, …See details»
Cyrus Biotechnology Announces $18M Financing and ... - SynBioBeta
Post-acquisition firm combines a proprietary software/AI biologics discovery platform with a massively-parallel protein screening capability, and a developing pipeline of pre-clinical and …See details»
Cyrus Biotechnology – Funding, Valuation, Investors, News
Jan 10, 2025 Cyrus Bio offers easy-to-use Computational Protein Engineering software on the cloud, accessed via a web-based GUI. We accelerate discovery and development in Biotech, …See details»
Cyrus Biotechnology Announces $18M Financing and Acquisition …
Dec 6, 2021 Lucas Nivon [email protected] 206-258-6561 Release Summary. Cyrus Biotechnology raises $18M, acquires Orthogonal Biologics to speed and expand new drug …See details»
Cyrus Biotechnology Announces $18M Financing and Acquisition …
Dec 6, 2021 Lucas Nivon [email protected] 206-258-6561 Back to Newsroom. Cyrus Biotechnology. Release Summary. Cyrus Biotechnology raises $18M, acquires Orthogonal …See details»
Cyrus Biotechnology Announces Selection of CYR212 as
Jan 9, 2025 Lucas Nivon [email protected] 206-258-6561 Release Summary Cyrus Biotech today announced that its protease CYR212 has been selected as its clinical candidate for …See details»